Doravirine Versus Integrase Inhibitors on Backbone of Emtricitabine and Tenofovir Alafenamide in HIV
Condition(s):HIV I Infection; Cardiovascular Risk Factor; Lipid Metabolism DisordersLast Updated:March 12, 2024Recruiting
Include Studies Not Open or Pending
Condition(s):HIV I Infection; Cardiovascular Risk Factor; Lipid Metabolism DisordersLast Updated:March 12, 2024Recruiting
Condition(s):HIV InfectionLast Updated:August 15, 2023Not yet recruiting
Condition(s):HIV/AIDS; Menopause; Inflammation VaginaLast Updated:April 7, 2023Recruiting
Condition(s):Pre-Exposure Prophylaxis of HIV InfectionLast Updated:February 23, 2024Recruiting
Condition(s):Pre-Exposure Prophylaxis of HIV InfectionLast Updated:March 22, 2024Recruiting
Condition(s):Aicardi Goutières SyndromeLast Updated:January 5, 2024Not yet recruiting
Condition(s):HIV Infections; ObesityLast Updated:November 14, 2023Recruiting
Condition(s):Acquired Immune Deficiency Syndrome (AIDS); HIV InfectionsLast Updated:February 20, 2024Recruiting
Condition(s):HIV/AIDS; Tuberculosis, PulmonaryLast Updated:March 15, 2024Recruiting
Condition(s):HIV-1 InfectionLast Updated:February 20, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.